Danilo Cangemi
Papers
1
Total Citations
6
H-Index
1
About
Danilo Cangemi is a researcher whose work sits at the critical intersection of urological oncology and molecular imaging, with a particular focus on improving the management of high-risk prostate cancer. His key contributions center on refining patient selection for PSMA-PET imaging, a powerful but nuanced tool for cancer staging. In his highly relevant 2024 study, Cangemi conducted an immunohistochemistry analysis of PSMA expression in prostatic biopsy samples from high-risk patients, directly correlating tissue-level protein presence with imaging outcomes. This work provides essential insights into why PSMA-PET results can vary, offering a potential biomarker-based strategy to identify which patients will benefit most from this advanced scan. By bridging the gap between histopathology and nuclear medicine, Cangemi’s research helps clinicians avoid unnecessary procedures and optimize treatment planning. With his work already garnering citations for its immediate clinical implications, he is establishing himself as a key voice in personalizing prostate cancer care through evidence-based imaging selection.
Research Focus
Key Achievements
Top Papers
- 1